华海药业(600521.SH)取得一项药品注册证书

Group 1 - The core point of the article is that Huahai Pharmaceutical has received approval from the National Medical Products Administration for the registration of Trimebutine Maleate Tablets [1] - Trimebutine Maleate Tablets are indicated for the improvement of symptoms related to gastrointestinal motility disorders, including loss of appetite, nausea, vomiting, belching, abdominal distension, borborygmi, abdominal pain, diarrhea, and constipation, as well as for irritable bowel syndrome [1]